| Talk to your healthcare provider if low blood sugar is a problem for you | Personalization This website is an international information resource intended only for Healthcare Professionals outside the US, Puerto Rico, Canada, UK and Ireland who are interested in information on Merck Products derived from the Product Information for Merck products in the EU |
|---|---|
| The British Journal of Radiology | "Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations" |
Mean change in body weight from baseline to week 29 was -1.
| Lactic Acidosis: Explain the risks of lactic acidosis, its symptoms, and conditions that predispose to its development | Zang M, Zuc collo A, Hou X, Nagata D, Walsh K, Herscovitz H, Brecher P, Ruderman NB, and Cohen RA: AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells |
|---|---|
| Symptoms included malaise, myalgias, respiratory distress, somnolence, and abdominal pain | Keep out of the reach and sight of children |
London: Royal College of Obstetricians and Gynaecologists.
| All values for biochemistry and hematology tests of blood and urine within the normal range or showied no clinically relevant deviation as judged by the Investigator• Maximum dosage: 2,000 mg per day | Wichtige Hinweise zu GLUCOPHAGE 500 mg Filmtabletten Hinweise zu den Bereichen Allergien betreffend Wirk- und Hilfsstoffe , Komplikationen mit Nahrungs- und Genussmitteln, sowie sonstige Warnhinweise |
|---|---|
| If higher doses are required, switch to GLUCOPHAGE at total daily doses up to 2550 mg administered in divided daily doses, as described above | Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease |
Marchesini G, Brizi M, Bianchi G, Tomassetti S, Zoli M, and Melchionda N: Metformin in non-alcoholic steatohepatitis.
12